Erin Quirk
2021
In 2021, Erin Quirk earned a total compensation of $1.7M as President and Chief Medical Officer at Terns Pharmaceuticals, a 56% decrease compared to previous year.
Compensation breakdown
| Bonus | $9,571 |
|---|---|
| Non-Equity Incentive Plan | $220,124 |
| Option Awards | $1,029,660 |
| Salary | $425,360 |
| Other | $7,500 |
| Total | $1,692,215 |
Quirk received $1M in option awards, accounting for 61% of the total pay in 2021.
Quirk also received $9.6K in bonus, $220.1K in non-equity incentive plan, $425.4K in salary and $7.5K in other compensation.
Rankings
In 2021, Erin Quirk's compensation ranked 6,728th out of 12,415 executives tracked by ExecPay. In other words, Quirk earned more than 45.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,728 out of 12,415 | 46th |
Division Manufacturing | 2,917 out of 5,508 | 47th |
Major group Chemicals And Allied Products | 1,284 out of 2,378 | 46th |
Industry group Drugs | 1,143 out of 2,099 | 46th |
Industry Pharmaceutical Preparations | 833 out of 1,549 | 46th |
Source: SEC filing on April 29, 2022.
Quirk's colleagues
We found two more compensation records of executives who worked with Erin Quirk at Terns Pharmaceuticals in 2021.